Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of a Combination of High Selenium Brassica Juncea With Irinotecan and Capecitabine

NCT00547547 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT00547547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00547547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of a Combination of High Selenium Brassica Juncea With Irinotecan and Capecitabine
Lead sponsor
City of Hope Medical Center
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2006
Completion date
August 31, 2012
Enrollment
22 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

unspecified adult solid tumor, protocol specific